Reactions have continued to trail the approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, with experts warning that its high cost could shut out millions of vulnerable people worldwide.
Trending
- SFH adopts new group structure
- RDI urges total ban on gas flaring
- Bauchi warns of dry spell, flood risk in 12 LGAs
- FG/IFAD scheme boosts farming in Nasarawa
- Lagos IGR hits 60% of budget — Sanwo-Olu
- House approves NSIB act amendment
- She farmers urge cluster farming for success
- Court approves key evidence in Malami’s trial
